Renal Function in Type 2 Diabetes with Rosiglitazone, Metformin, and Glyburide Monotherapy

SUMMARY: BACKGROUND AND OBJECTIVES: In ADOPT (A Diabetes Outcomes Prevention Trial), initial monotherapy with rosiglitazone provided more durable glycemic control than metformin or glyburide in patients with recently diagnosed type 2 diabetes. Herein, we examine differences in albumin excretion, ren...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Lachin, John M., Viberti, Giancarlo, Zinman, Bernard, Haffner, Steven M., Aftring, R. Paul, Paul, Gitanjali, Kravitz, Barbara G., Herman, William H., Holman, Rury R., Kahn, Steven E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Nephrology 2011
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3087768/
https://ncbi.nlm.nih.gov/pubmed/21454723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.09291010
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller